메뉴 건너뛰기




Volumn 6, Issue 6, 2009, Pages 543-545

Biomarkers in chronic obstructive pulmonary disease

Author keywords

Biomarker; COPD; Drug discovery

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLARA CELL SECRETORY PROTEIN 16; ELASTIN ANTIBODY; EOTAXIN 2; FIBRINOGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; N ACETYLPROLYLGLYCYLPROLINE; PULMONARY AND ACTIVATION REGULATED CHEMOKINE; SERUM AMYLOID A; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

EID: 70349109207     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200904-019DS     Document Type: Conference Paper
Times cited : (63)

References (33)
  • 1
    • 2942729608 scopus 로고    scopus 로고
    • Management of chronic obstructive pulmonary disease
    • Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 2004;350:2689-2697.
    • (2004) N Engl J Med , vol.350 , pp. 2689-2697
    • Sutherland, E.R.1    Cherniack, R.M.2
  • 4
    • 0033603794 scopus 로고    scopus 로고
    • Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points: evidence-based medicine working group
    • Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points: evidence-based medicine working group. JAMA 1999;282:771-778.
    • (1999) JAMA , vol.282 , pp. 771-778
    • Bucher, H.C.1    Guyatt, G.H.2    Cook, D.J.3    Holbrook, A.4    Mcalister, F.A.5
  • 5
    • 70349141385 scopus 로고    scopus 로고
    • U.S. Department of health and human services food and drug administration center for drug evaluation and research (CDER)
    • accessed April 14, 2009. Available from
    • U.S. Department of health and human services food and drug administration center for drug evaluation and research (CDER). Guidance for industry chronic obstructive pulmonary disease: Developing drugs for treatment. 2007 [accessed April 14, 2009]. Available from: http:// www.fda.gov/CDER/GUIDANCE/7875dft.pdf.
    • (2007) Guidance for Industry Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment
  • 6
    • 33744990865 scopus 로고    scopus 로고
    • ABC of chronic obstructive pulmonary disease: Diagnosis
    • Currie GP, Legge JS. ABC of chronic obstructive pulmonary disease: diagnosis. BMJ 2006;332:1261-1263. (Pubitemid 44365420)
    • (2006) British Medical Journal , vol.332 , Issue.7552 , pp. 1261-1263
    • Currie, G.P.1    Legge, J.S.2
  • 7
    • 0025331018 scopus 로고
    • Abnormal pulmonary function specifically related to congestive heart failure: Comparison of patients before and after cardiac transplantation
    • DOI 10.1016/0002-9343(90)90428-G
    • Hosenpud JD, Stibolt TA, Atwal K, Shelley D. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med 1990;88:493-496. (Pubitemid 20168725)
    • (1990) American Journal of Medicine , vol.88 , Issue.5 , pp. 493-496
    • Hosenpud, J.D.1    Stibolt, T.A.2    Atwal, K.3    Shelley, D.4
  • 8
    • 33646565124 scopus 로고    scopus 로고
    • Outcomes and markers in the assessment of chronic obstructive pulmonary disease
    • DOI 10.1183/09031936.06.00145104
    • Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006;27:822-832. (Pubitemid 44914209)
    • (2006) European Respiratory Journal , vol.27 , Issue.4 , pp. 822-832
    • Jones, P.W.1    Agusti, A.G.N.2
  • 12
    • 57349122437 scopus 로고    scopus 로고
    • Quantitative computed tomography assessment of airway wall dimensions: Current status and potential applications for pheno-typing chronic obstructive pulmonary disease
    • Coxson HO. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for pheno-typing chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:940-945.
    • (2008) Proc Am Thorac Soc , vol.5 , pp. 940-945
    • Coxson, H.O.1
  • 13
    • 45149088260 scopus 로고    scopus 로고
    • Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: Intra-patient and inter-patient variability
    • DOI 10.1136/thx.2007.086751
    • Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Interrelationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008;63:493-499. (Pubitemid 351831157)
    • (2008) Thorax , vol.63 , Issue.6 , pp. 493-499
    • Sapey, E.1    Bayley, D.2    Ahmad, A.3    Newbold, P.4    Snell, N.5    Stockley, R.A.6
  • 15
    • 33646575644 scopus 로고    scopus 로고
    • Emerging drugs for the treatment of chronic obstructive pulmonary disease
    • DOI 10.1517/14728214.11.2.275
    • Malhotra S, Man SF, Sin DD. Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs 2006;11:275-291. (Pubitemid 43723309)
    • (2006) Expert Opinion on Emerging Drugs , vol.11 , Issue.2 , pp. 275-291
    • Malhotra, S.1    Man, S.F.P.2    Sin, D.D.3
  • 17
    • 0031001720 scopus 로고    scopus 로고
    • Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study
    • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-1504.
    • (1997) Lancet , vol.349 , pp. 1498-1504
    • Murray, C.J.1    Lopez, A.D.2
  • 19
    • 33749998694 scopus 로고    scopus 로고
    • C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
    • DOI 10.1136/thx.2006.059808
    • Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-853. (Pubitemid 44570304)
    • (2006) Thorax , vol.61 , Issue.10 , pp. 849-853
    • Man, S.F.P.1    Connett, J.E.2    Anthonisen, N.R.3    Wise, R.A.4    Tashkin, D.P.5    Sin, D.D.6
  • 22
    • 34548034720 scopus 로고    scopus 로고
    • The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)
    • DOI 10.3132/pcrj.2007.00047
    • Garrod R, Marshall J, Barley E, Fredericks S, Hagan G. The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2007;16:236-240. (Pubitemid 47281449)
    • (2007) Primary Care Respiratory Journal , vol.16 , Issue.4 , pp. 236-240
    • Garrod, R.1    Marshall, J.2    Barley, E.3    Fredericks, S.4    Hagan, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.